Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Elyssa Maufras du Châtellier

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Philippe Dutheil

Investment Director

Mailys Ferrere

Director of Large Venture Investments

Paul-Francois Fournier

Executive Director, Innovation Department

Pierre Gillet

Investment Director

Vanessa Giraud

Director of Environmental Impact Funds

Gwenael Hamon

Investment Director

Laurent Higueret Ph.D

Senior Investment Director

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Chahra Louafi

Senior Investment Director

Serge Mesguich

Director of FIT

Laure Michel

Investment Director

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Néel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Director

Jean-Marie Fougeray

Senior Investment Director, Brittany

Past deals in Personal Health

H'ability

Seed Round in 2025
H'ability specializes in providing immersive virtual reality (VR) therapeutic exercises that complement traditional rehabilitation methods. The company offers a wireless VR headset with customizable exercises targeting motor skills, balance, and cognitive functions. Their platform features real-time session personalization, detailed progress tracking with data analytics, and compatibility with additional rehabilitation tools. This enables healthcare professionals to deliver personalized, engaging, and efficient therapy sessions in clinical settings or at patients' homes, catering to various medical conditions.

Fizimed

Venture Round in 2025
Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.

Doado

Seed Round in 2024
Doado is a health technology company that specializes in developing mobile applications for back health management. Its primary product is an e-health application designed to guide users step by step in improving their back health and preventing Musculoskeletal Disorders. The application offers personalized video programs, expert advice from physiotherapists and doctors, and AI-driven progress tracking, enabling individuals and companies to maintain an active lifestyle and reduce the risk of chronic back pain.

Metyos

Pre Seed Round in 2024
Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing users' day-to-day data, including fat levels and energy metabolism dynamics, Metyos provides personalized fitness and nutrition routines. The company's aim is to help individuals understand how their bodies respond to their actions, thereby empowering them to achieve their weight goals and regain control over their health.

Callyope

Seed Round in 2023
Callyope is a technology company focused on enhancing brain health monitoring through human-centered solutions. By developing a speech-based platform that utilizes natural language processing and signal processing techniques, Callyope enables caregivers to monitor patients' brain functionality more effectively. The platform allows for a detailed examination of patients' verbal productions, providing valuable insights that help identify relapses and inform treatment decisions. Ultimately, Callyope aims to improve the quality of life for patients while also contributing to a reduction in re-hospitalization rates.

Teale

Series A in 2023
Teale is a prominent digital mental health platform that integrates psychology and technology to facilitate mental health care for individuals and organizations. The company offers personalized and engaging digital healthcare solutions, emphasizing the importance of subconscious well-being. Teale's approach includes individual support and collective workshops tailored to the specific needs of users, thereby enhancing the effectiveness of mental health initiatives. Through its curated network of mental health experts, Teale enables employees to assess their mental health status and access customized digital programs designed to promote their psychological resilience.

Numa Health

Seed Round in 2023
Numa Health is a medical bioinformatics health technology company that focuses on empowering individuals to optimize their health capital and well-being. It has developed a digital health platform that offers tools designed to enhance users' commitment to their health. This platform facilitates the reinterpretation of blood test results, providing insights into bodily functions and overall health. By enabling users to measure, understand, and take actionable steps regarding their health, Numa Health aims to support individuals in their journey towards better health management.

Maddie

Venture Round in 2023
Maddie is a healthcare technology company that offers software solutions designed for physiotherapists and other health professionals. Its platform enables effective practice management through features such as dematerialized diaries, online appointment bookings, and customizable websites. These tools assist healthcare providers in organizing waiting lists, optimizing schedules, and managing incoming requests efficiently. By streamlining administrative tasks, Maddie aims to enhance the operational capabilities of health professionals, allowing them to focus more on patient care.

Microphyt

Series B in 2022
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Lola Health

Pre Seed Round in 2022
Lola Health is an insurance technology company that specializes in providing personalized complementary health insurance solutions. The firm focuses on enhancing traditional insurance offerings by including support for specific care pathways such as endometriosis, parenthood, postpartum depression, psychology, and alternative medicine. Lola Health's services are designed to assist businesses in retaining employees, attracting new talent, and improving overall performance. Key offerings include Angel Plus, an advisory platform that helps employees find solutions, telecommunications services, and psychological support. The company aims to make insurance more accessible and reduce risk by providing numerous assistance and prevention services.

Cuure

Series A in 2022
Cuure is a company specializing in personalized vitamins and supplements designed to meet individual health needs. Through a combination of health questionnaires and DNA analysis, Cuure creates customized supplement plans aimed at optimizing overall wellness. The company's platform offers tailored recommendations based on scientific research, ensuring that users receive the appropriate dosages of vitamins, minerals, and plant-based ingredients suited to their specific health goals and body chemistry. Additionally, Cuure incorporates a tracking application to help individuals foster wellness habits, making it easier for them to integrate these personalized solutions into their daily routines.

Susu

Debt Financing in 2022
Susu is a health tech company focused on making healthcare accessible and affordable for individuals within the African diaspora. It offers a comprehensive range of health services, including preventive care, medical treatments, chronic disease management, and the provision of authentic medications. The company operates a platform that delivers health bundle services, ensuring planned, long-term health support for patients. This approach facilitates optimal monitoring of various health conditions, such as pregnancy and chronic diseases, enabling users to access quality healthcare services and insurance. Through its innovative offerings, Susu aims to enhance healthcare access for families across the African diaspora.

Susu

Grant in 2022
Susu is a health tech company focused on making healthcare accessible and affordable for individuals within the African diaspora. It offers a comprehensive range of health services, including preventive care, medical treatments, chronic disease management, and the provision of authentic medications. The company operates a platform that delivers health bundle services, ensuring planned, long-term health support for patients. This approach facilitates optimal monitoring of various health conditions, such as pregnancy and chronic diseases, enabling users to access quality healthcare services and insurance. Through its innovative offerings, Susu aims to enhance healthcare access for families across the African diaspora.

WhatMatters

Seed Round in 2022
WhatMatters offers cosmetics geared for home and hygiene care. They sell items including toothpaste, shower gel, hand sanitizer, cleansing water, dish soap, laundry detergent, and more. They provide a range of products for children as well.

Heroic sante

Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Omini

Seed Round in 2021
Omini is a biotechnology company based in Saint Mandé, France, founded in 2019. It specializes in the development of portable and multipurpose bio-sensing devices designed for immediate blood testing. Omini's biosensor platform enables the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to customize therapies and prevent acute crises in patients with chronic conditions. By leveraging multiplex electrochemical biosensor technology, the company offers affordable and accurate monitoring solutions that facilitate decentralized testing and at-home monitoring, ultimately helping to alleviate the burden on healthcare systems. Omini primarily serves general practitioners, aiming to enhance patient care through innovative diagnostic tools.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Kwit

Series A in 2021
Kwit is a company that specializes in smoking cessation through the development of a mobile application aimed at helping users quit smoking. The application employs evidence-based scientific methods and incorporates principles of cognitive and behavioral therapy. By providing daily support infused with positivity and kindness, Kwit guides users on their journey to achieve a smoke-free life, ultimately enabling them to lead healthier and happier lives.

Lucine

Seed Round in 2020
Lucine is a company focused on improving patient health, primarily targeting pain management. It develops a mobile health application that offers a digital therapeutic solution designed to relieve pain within five minutes through analgesic neurostimulation. The application employs advanced algorithms to measure and analyze pain by utilizing facial, vocal, and postural recognition. This technology allows for personalized treatment, as it instantly adapts to each patient's specific needs. The application provides a variety of techniques to alleviate pain symptoms, including exercises, relaxation methods, art therapy, and meditation, empowering patients with chronic pain to manage their conditions effectively from home.

Medaviz

Series A in 2020
Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that connects patients with healthcare professionals for immediate medical advice. The platform allows users to contact general practitioners, pediatricians, gynecologists, and psychologists at any time, facilitating access to necessary assistance for various medical issues and emergencies. By enabling direct communication between patients and doctors, Medaviz aims to streamline the process of obtaining medical guidance and support.

Withings

Series B in 2020
Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.

Exeliom

Grant in 2019
Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

Microphyt

Venture Round in 2019
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Fizimed

Seed Round in 2018
Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.

Nomadeec

Venture Round in 2017
Nomadeec is a mobile telemedicine platform developed by Exelus SAS, specializing in emergency and scheduled care. As a leader in remote medical control in France, Nomadeec offers a powerful and intuitive tool that enhances decision-making in urgent situations, thereby improving patient outcomes. The platform is versatile and tailored to the needs of various healthcare professionals, including emergency doctors, sports physicians, and paramedics. It facilitates real-time communication between healthcare providers and patients, enabling teleconsultations, tele-expertise, and tele-triage. By optimizing the quality of prehospital care, Nomadeec effectively addresses healthcare access issues in underserved areas and helps prevent unnecessary hospitalizations, allowing healthcare professionals to deliver timely assistance in both emergency and routine medical contexts.

Withings

Series B in 2013
Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.